YouTube Facebook LinkedIn Google+ Twitter Xingrss  



May 9, 2003 | The Mirus Genomic Index, prepared exclusively for Bio·IT World, is calculated as the sum of the market capitalizations of all included companies and is consequently a value-weighted index. It serves as an indicator of the financial health of the industry. The index was developed at RCW Mirus (www.merger.com), an investment banking firm, by David Hoffer and colleagues at the firm's Boston headquarters.


Discovery Companies 

Company

Market
Cap1 
Revenues
TTM2 
Net Income
TTM2

Celera Genomics (CRA)

616.0 105.1  (114.1)

CuraGen Corp. (CRGN)

203.6 18.3  (90.4)

deCODE genetics Inc. (DCGN)

99.0 38.2  (130.0)

Deltagen Inc. (DGEN)

13.9 15.4  (101.0)

DNAPrint Genomics (DNAP.OB)

9.0 0.1  (3.5)

Exelixis Inc. (EXEL)

401.7 44.3  (85.0)

Genome Therapeutics Corp. (GENE)

33.5 23.0  (34.0)

Human Genome Sciences (HGSI)

1096.9 3.6  (219.7)

Hyseq Inc. (HYSQ)

18.4 33.9  (29.9)

Incyte Genomics Inc. (INCY)

203.7 101.6  (136.8)

Interleukin Genetics Inc. (ILGN)

12.9 0.3  (5.3)

Lexicon Genetics Inc. (LEXG)

222.7 35.2  (59.7)

Millennium Pharmaceuticals (MLNM)

2431.9 353.1  (590.2)

Myriad Genetics Inc. (MYGN)

279.7 59.7  (22.5)

Oxford GlycoSciences (ADR) (OGSI)

166.2 16.1  (58.2)

Rigel Pharmaceuticals Inc. (RIGL)

32.4 15.8  (37.0)

Sequenom Inc. (SQNM)

74.9 30.9  (205.2)

Vertex Pharmaceuticals (VRTX)

840.4 161.1  (108.7)

Q1 2003 Index = 6,757 




Tools Companies 

Company

Market
Cap1 
Revenues
TTM2 
Net Income
TTM2 

Aclara Biosciences (ACLA)

72.6 2.6 (37.3)

Affymetrix Inc. (AFFX)

1560.4 289.9 (1.7)

Applied Biosystems Group (ABI)

3329.0 1666.6 150.6

Ciphergen Biosystems (CIPH)

155.3 39.3 (29.1)

Compugen Ltd. (CGEN)

48.6 11.1 (12.2)

Epoch Biosciences Inc. (EBIO)

39.8 11.3 (3.2)

Harvard Bioscience Inc. (HBIO)

110.7 57.4 0.7

Illumina Inc. (ILMN)

76.7 10.1 (40.3)

Invitrogen Corp. (IVGN)

1528.5 648.6 47.7

LION bioscience AG (ADR) (LEON)

61.7 36.6 (165.3)

Luminex Corp. (LMNX)

135.3 13.1 (24.3)

Qiagen N.V. (QGENF)

858.5 298.3 23.2

Third Wave Technologies (TWTI)

130.0 32.3 (40.8)

Transgenomic Inc. (TBIO)

38.8 37.5 (15.4)

Varian Inc. (VARI)

996.8 791.4 51.8

Q1 2003 Index = 9,143 

  1. Market cap is number of shares outstanding x share price as of April 2, 2003 (in $ millions).
  2. TTM is trailing 12 months ending Dec. 31, 2002, for all companies except Deltagen and DNAPrint Genomics, for which TTM ends Sept. 30, 2002, and Oxford GlycoSciences, for which TTM ends June 30, 2002 (all financials in $ millions).
  3. TTM is trailing 12 months ending Dec. 31, 2002, for all companies (all financials in $ millions).

RCW Mirus Inc. does not assume any liability for errors or omissions. 



Back to Discovering the Joy of Cannibalism 



For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.